The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression
about
CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanismsKruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesisDevelopmental therapeutics for inflammatory breast cancer: Biology and translational directionsRegulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors"MYC and the control of DNA replication.HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.A novel role of proteasomal β1 subunit in tumorigenesis.Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemiaA conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest.Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction pointRegulation of CDK4A New Double Stranded RNA Suppresses Bladder Cancer Development by Upregulating p21 (Waf1/CIP1) Expression.Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion.Effects of tachyplesin on the regulation of cell cycle in human hepatocarcinoma SMMC-7721 cells.Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activityCDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells.Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.Myc's broad reach.Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.Adenovirus-mediated delivery of p27(KIP1) to prevent wound healing after experimental glaucoma filtration surgery.Lentiviral vector-mediated siRNA knockdown of c-MYC: cell growth inhibition and cell cycle arrest at G2/M phase in Jijoye cells.Arginine deiminase originating from Lactococcus lactis ssp. lactis American Type Culture Collection (ATCC) 7962 induces G1-phase cell-cycle arrest and apoptosis in SNU-1 stomach adenocarcinoma cells.Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction.A large scale genetic analysis of c-Myc-regulated gene expression patterns.Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.RNAm expression profile of cancer marker genes in HepG2 cells treated with different concentrations of a new indolin-3-one from Pseudomonas aeruginosa
P2860
Q24302257-CD2E5B1F-9869-45A4-917D-A62854BFB2E3Q24606774-0158C02F-D7F3-446E-9113-8E6E9DF76AF7Q28075322-0F05F34F-9B5D-44B7-95B3-609B0D978D43Q28246814-711F71B7-FF6D-4BC4-897A-329C1A06CA0DQ33653686-222C871B-D6A4-46DA-9E17-E0734B033F14Q33705004-7A27E89E-80CF-4984-B3C1-32736C526DBCQ34347861-D9A3E04A-926F-420F-B20B-E1ADD19DBE07Q34349298-9016E7D1-B370-4BA5-986E-A0E72013014BQ34718058-60A1940D-1C2A-412B-AC77-AD7CED0F9E25Q34812632-2E527ECE-555F-4779-B312-82E65512FAABQ35147982-5775269D-949F-418A-A17E-E1B174FA503CQ35402181-2B134791-3AEE-4FA3-9B53-59367F55E8CAQ36140644-F5C76CDD-4705-41DB-A2C4-6745BA1F0B4BQ36209702-B300AB92-B81A-470A-8D5A-AFA9EC08BD0CQ36421097-0BC0E054-2EB0-49BC-B473-2044ADD150E9Q36518627-FC493A72-91AD-482F-9836-349FC5B41625Q37275203-E30B0BDE-1EAB-4F9F-99DB-30C7C1A031EAQ37299032-0334F2A7-82AB-4905-A978-DBB4FE3642F8Q37825724-F5608153-A091-4C82-9BC0-19D33CDABFE1Q37958637-2C590FC1-705B-4135-98BD-52D6EE7C21E8Q39010573-E45E8DD5-CD42-4590-8894-EEA9B9190D2DQ39154624-4989E589-68C0-4BFE-83B7-7E11E87055ACQ39822200-6BD61904-5DF5-4902-A6EC-BFF715866B76Q40106453-CFE61B44-6942-4699-AAA0-33495B2B87DAQ40677486-7D1AFF11-29B8-4329-ADAD-C9C63A7F481FQ44429267-A607F532-1DC1-4B8D-A659-5B3E9BF46342Q58708198-EEFDB148-CC1E-41E4-BBA4-CBF3F0920A89
P2860
The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression
description
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im August 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/08/23)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/08/23)
@nl
наукова стаття, опублікована в серпні 2002
@uk
مقالة علمية (نشرت في 23-8-2002)
@ar
name
The proto-oncogene c-myc acts ...... d early G(1) phase progression
@en
The proto-oncogene c-myc acts ...... d early G(1) phase progression
@nl
type
label
The proto-oncogene c-myc acts ...... d early G(1) phase progression
@en
The proto-oncogene c-myc acts ...... d early G(1) phase progression
@nl
prefLabel
The proto-oncogene c-myc acts ...... d early G(1) phase progression
@en
The proto-oncogene c-myc acts ...... d early G(1) phase progression
@nl
P2093
P2860
P356
P1476
The proto-oncogene c-myc acts ...... d early G(1) phase progression
@en
P2093
Alvaro J. Obaya
Iulia Kotenko
John M. Sedivy
Michael D. Cole
P2860
P304
31263–31269
P356
10.1074/JBC.M202528200
P407
P577
2002-08-23T00:00:00Z